Kabaya Shokuhin Okayama Factory

10 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNSAFE COL8 refused lines

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

• COLOR LBLG2 refused lines

  Artificial coloring not declared

  The product appeared to contain an artificial coloring without labeling that states that fact.

Questions about Kabaya Shokuhin Okayama Factory

Is Kabaya Shokuhin Okayama Factory on an FDA import alert?

Yes. As of October 26, 2026, Kabaya Shokuhin Okayama Factory is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for gummy candy grape flavor (pureral gummy grape soft candy); FDA published the listing on July 22, 2019.

Has FDA refused shipments from Kabaya Shokuhin Okayama Factory?

Yes. FDA refused 8 shipment lines from Kabaya Shokuhin Okayama Factory between March 18, 2019 and May 26, 2021. The most recent, on May 26, 2021, was jellied candy, soft (jelly beans, gum drops, etc.), without nuts and fruit (without chocolate), charged as UNSAFE COL (color additive unsafe under section 721).

Why did FDA refuse Kabaya Shokuhin Okayama Factory's shipments?

The most frequent charges are UNSAFE COL (color additive unsafe under section 721, 8 lines) and COLOR LBLG (artificial coloring not declared, 2 lines).

When was Kabaya Shokuhin Okayama Factory last inspected by FDA?

FDA's most recent inspection of Kabaya Shokuhin Okayama Factory with a final classification is dated January 19, 2015 and was classified NAI (No Action Indicated).

What is Kabaya Shokuhin Okayama Factory's FEI number?

Kabaya Shokuhin Okayama Factory's FDA Establishment Identifier (FEI) is 2000009604.

Can shipments from Kabaya Shokuhin Okayama Factory still enter the U.S.?

Shipments of gummy candy grape flavor (pureral gummy grape soft candy) from Kabaya Shokuhin Okayama Factory can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).